Aramchol meglumine

DRUG2 trials

Sponsors

Galmed Pharmaceuticals Ltd

Conditions

HealthyPrimary Sclerosing Cholangitis

Phase 1

Comparing The PK Of Aramchol Meglumine Granules To Aramchol Free Acid Tablets

CompletedNCT06502561

Galmed Pharmaceuticals LtdHealthy

Start: 2025-02-15End: 2025-11-17Updated: 2026-06-01

Phase 2

A Study Evaluating the Safety, Tolerability, and Efficacy of Aramchol Meglumine in Primary Sclerosing Cholangitis

WithdrawnNCT06095986

Galmed Pharmaceuticals LtdPrimary Sclerosing Cholangitis

Start: 2025-06-30End: 2027-12-31Updated: 2025-06-12